Home1734 • TPE
add
Sinphar Pharmaceutical Co Ltd
Previous close
$30.55
Day range
$30.60 - $30.85
Year range
$28.60 - $36.30
Market cap
5.54B TWD
Avg Volume
285.11K
P/E ratio
16.68
Dividend yield
3.03%
Primary exchange
TPE
Market news
Financials
Income Statement
Revenue
Net income
(TWD) | Sep 2024info | Y/Y change |
---|---|---|
Revenue | 749.52M | 4.72% |
Operating expense | 217.37M | -0.80% |
Net income | 47.62M | -37.47% |
Net profit margin | 6.35 | -40.32% |
Earnings per share | — | — |
EBITDA | 116.02M | 3.04% |
Effective tax rate | 12.34% | — |
Balance Sheet
Total assets
Total liabilities
(TWD) | Sep 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 1.16B | 15.79% |
Total assets | 6.26B | 1.64% |
Total liabilities | 2.79B | -3.46% |
Total equity | 3.47B | — |
Shares outstanding | 181.14M | — |
Price to book | 1.74 | — |
Return on assets | 2.16% | — |
Return on capital | 2.58% | — |
Cash Flow
Net change in cash
(TWD) | Sep 2024info | Y/Y change |
---|---|---|
Net income | 47.62M | -37.47% |
Cash from operations | 199.62M | 250.67% |
Cash from investing | -91.80M | 25.49% |
Cash from financing | -104.77M | -418.58% |
Net change in cash | 7.03M | 131.49% |
Free cash flow | 134.44M | 158.41% |
About
Founded
1977
Headquarters
Website
Employees
984